» Articles » PMID: 16989815

Quantitative Comparison of the Efficiency of Antibodies Against S1 and S2 Subunit of SARS Coronavirus Spike Protein in Virus Neutralization and Blocking of Receptor Binding: Implications for the Functional Roles of S2 Subunit

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2006 Sep 23
PMID 16989815
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Neutralizing effects of antibodies targeting the C-terminal stalk (S2) subunit of the spike protein of severe acute respiratory syndrome coronavirus have previously been reported, although its mechanism remained elusive. In this study, high titered mouse antisera against the N-terminal globular (S1) and S2 subunits of the S protein were generated and total immunoglobulin G (IgG) was purified from these antisera. The efficiency of these purified IgGs in virus neutralization and blocking of receptor binding were compared quantitatively using virus neutralization assay and a previously developed cell-based receptor binding assay, respectively. We demonstrated that anti-S1 IgG neutralizes the virus and binds to the membrane associated S protein more efficiently than anti-S2 IgG does. Moreover, both anti-S1 and anti-S2 IgGs were able to abolish the binding between S protein and its cellular receptor(s), although anti-S1 IgG showed a significantly higher blocking efficiency. The unexpected blocking ability of anti-S2 IgG towards the receptor binding implied a possible role of the S2 subunit in virus docking process and argues against the current hypothesis of viral entry. On the other hand, the functional roles of the previously reported neutralizing epitopes within S2 subunit were investigated using an antigen specific antibody depletion assay. Depletion of antibodies against these regions significantly diminished, though not completely abolished, the neutralizing effects of anti-S2 IgG. It suggests the absence of a major neutralizing domain on S2 protein. The possible ways of anti-S2 IgGs to abolish the receptor binding and the factors restricting anti-S2 IgGs to neutralize the virus are discussed.

Citing Articles

Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice.

Halfmann P, Patel R, Loeffler K, Yasuhara A, Van de Velde L, Yang J Nat Commun. 2025; 16(1):462.

PMID: 39774966 PMC: 11706982. DOI: 10.1038/s41467-025-55824-y.


Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection.

Olukitibi T, Ao Z, Warner B, Unat R, Kobasa D, Yao X Vaccines (Basel). 2023; 11(3).

PMID: 36992129 PMC: 10056353. DOI: 10.3390/vaccines11030545.


Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.

Zedan H, Yassine H, Al-Sadeq D, Liu N, Qotba H, Nicolai E Sci Rep. 2022; 12(1):19020.

PMID: 36347859 PMC: 9643483. DOI: 10.1038/s41598-022-21317-x.


Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies.

Maghsood F, Amiri M, Zarnani A, Salimi V, Kardar G, Khoshnoodi J Front Med (Lausanne). 2022; 9:973036.

PMID: 36148457 PMC: 9485472. DOI: 10.3389/fmed.2022.973036.


Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins.

Findlay-Wilson S, Easterbrook L, Smith S, Pope N, Humphries G, Schuhmann H Antiviral Res. 2022; 203:105332.

PMID: 35533779 PMC: 9075985. DOI: 10.1016/j.antiviral.2022.105332.


References
1.
Lip K, Shen S, Yang X, Keng C, Zhang A, Janice Oh H . Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus. J Virol. 2005; 80(2):941-50. PMC: 1346840. DOI: 10.1128/JVI.80.2.941-950.2006. View

2.
Guan Y, Zheng B, He Y, Liu X, Zhuang Z, Cheung C . Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003; 302(5643):276-8. DOI: 10.1126/science.1087139. View

3.
Chow K, Yeung Y, Hon C, Zeng F, Law K, Leung F . Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells. FEBS Lett. 2005; 579(30):6699-704. PMC: 7094440. DOI: 10.1016/j.febslet.2005.10.065. View

4.
Sainz Jr B, Rausch J, Gallaher W, Garry R, Wimley W . The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry. Biochemistry. 2005; 44(3):947-58. DOI: 10.1021/bi048515g. View

5.
Hofmann H, Pohlmann S . Cellular entry of the SARS coronavirus. Trends Microbiol. 2004; 12(10):466-72. PMC: 7119031. DOI: 10.1016/j.tim.2004.08.008. View